DouglasScottScherrMD

Surgical Oncology

Professor of Urology and the Clinical Director of Urologic Oncology Weill Cornell Medicine

Overview of Dr. Scherr

Dr. Douglas Scherr is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and New York-Presbyterian Hospital. He received his medical degree from George Washington University School of Medicine and has been in practice 23 years. He specializes in surgical oncology and is experienced in prostate cancer, gynecologic oncology, urogynecology and pelvic reconstructive surgery, pediatric urology, and urologic oncology.

Office
525 E 68th St
# 94
New York, NY 10065
Book by Phone+1(229) 360-6105

Fax+1 212-746-8197

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2000 - 2002
New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 1996 - 2000
George Washington UniversityResidency, Surgery, 1994 - 1996
George Washington University School of Medicine and Health SciencesClass of 1994

Certifications & Licensure

NY State Medical License 1996 - 2025
American Board of Urology Urology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
Top Doctors: New York Metro Area Castle Connolly, 2007-2014
New York Magazine: Top Doctors Castle Connolly, 2006-2014
America's Top Doctors for Cancer Castle Connolly, 2007-2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Join now to see all

Clinical Trials

Use of Multiphoton Microscopy in the Diagnosis of Cancer Start of enrollment: 2005 Jun 01
Completed
Phase 1
Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients Start of enrollment: 2009 Sep 01
Terminated
Phase 3
Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection Start of enrollment: 2012 Jan 01
Completed
Phase 1
Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer Start of enrollment: 2016 Dec 01
Completed
HIPEC After Radical Cystectomy for High Risk Bladder Cancer Start of enrollment: 2018 Apr 19
Completed
Not Applicable
PSMA Imaging of Localized Prostate Cancer Start of enrollment: 2017 Feb 08
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

4 citations
The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution.
Duy D Nguyen, William F Hooper, Weisi Liu, Timothy R Chu, Heather Geiger
Nature. 2024-11-01
Ascertaining provider-level implicit bias in electronic health records with rules-based natural language processing: A pilot study in the case of prostate cancer.
Ashwin Ramaswamy, Michael Hung, Joe Pelt, Parsa Iranmahboub, Lina P Calderon
Plos One. 2024-01-01
1 citations
A Pilot Study on Hyperthermic Intraperitoneal Chemotherapy after Radical or Partial Cystectomy with Pelvic Lymph Node Dissection for High-risk Muscle-invasive Bladder ...
Leonardo D Borregales, Siv Venkat, Lina Posada Calderon, Patrick Lewicki, Thomas Flynn
European Urology. 2023-12-01

Press Mentions

A Disturbing Rise in Prostate CancerApril 1st, 2023
Risk Stratification of Upper Tract Urothelial Carcinoma - Doug ScherrAugust 27th, 2021
Doctors Can Now Detect Hard-to-Diagnose Prostate CancerAugust 9th, 2012
Join now to see all

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPO
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
MVP Healthcare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment